Stay updated with breaking news from Axgn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com lowered shares of AxoGen (NASDAQ:AXGN – Free Report) from a buy rating to a hold rating in a research report sent to investors on Saturday. AXGN has been the subject of several other research reports. Cantor Fitzgerald reiterated an overweight rating and set a $16.00 price target on shares of AxoGen in a research […] ....
By Will Feuer Shares of Axogen jumped after the company, which makes surgical solutions for peripheral nerve injuries, said revenue for 2023 should come in. ....
AxoGen, Inc. (NASDAQ:AXGN – Get Free Report) CFO Peter J. Mariani sold 12,500 shares of the stock in a transaction dated Monday, December 11th. The stock was sold at an average price of $7.50, for a total transaction of $93,750.00. Following the sale, the chief financial officer now owns 63,603 shares in the company, valued […] ....
ArrowMark Colorado Holdings LLC grew its position in shares of AxoGen, Inc. (NASDAQ:AXGN – Free Report) by 7.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 3,921,033 shares of the medical equipment provider’s stock after acquiring an additional 263,422 shares during the period. ArrowMark Colorado Holdings LLC owned about 0.09% of AxoGen worth $35,799,000 […] ....